RxDoctor Payments Data

Rick Bernstein, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Las Vegas, NVNPI 1932182029

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (33.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Cardiovascular Systems Inc. at 36.9% of the total. Reporting peaked in 2021 at $4,364 and has fallen 56.9% since, to $1,880 in 2025.

$15,711in general payments, 2019–2025

Across 171 payments — averaging $91.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cardiovascular Systems Inc.$6K
  • Medtronic$2K
  • Bard Peripheral Vascular, Inc.$2K
  • Abbott$2K
  • Angiodynamics, Inc.$1K
  • Cook Medical LLC$882
  • plus $2K from 20 others

What the payments were for

  • Speaking & faculty fees$5,24033%
  • Travel & lodging$5,29234%
  • Food & beverage$5,17933%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,711 in reported general payments places this provider in the 80th percentile of 41 thoracic surgery (cardiothoracic vascular surgery) providers in Nevada.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Nevada

Medicare billing

Part B allowed, 2024
$210,641
Medicare patients
106
Services billed
485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban60$43,702
EliquisApixaban17$11,955
Cilostazol34$427
ClopidogrelClopidogrel Bisulfate55$362

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →